The EPS projection of TearLab Corporation (NASDAQ:TEAR) for quarter ended 2016-09-30 is $-0.07. Last week, the EPS forecast was $-0.07 against target of $-0.07, a month earlier. Two months ago, this estimate was $-0.07 versus forecast of $-0.07 three months earlier, implying a deviation of 0%.
TearLab Corporation (NASDAQ:TEAR) stated that 18 days ago, its stock price was positively revised 2 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 2, 3, and 3, correspondingly.
EPS estimate downgrade for TearLab Corporation (NASDAQ:TEAR) in the preceding 30, 120, 60 and 90 days were 0, 0, 0, and 0, correspondingly.
TearLab Corporation (NASDAQ:TEAR) EPS target for the quarter closed 1 was $-0.07, based on 3 recommendations. As reported on 2016-05-04 the EPS was $-0.21. The change was $0.02, implying a percentage deviation of 8.7%. The projections showed a standard deviation of 0.02.
Quarterly Sales Estimates
TearLab Corporation (NASDAQ:TEAR) yearly sales prediction for the fiscal 2016 stands at $8.013 and the median estimate is at $8.1. Almost 3 analysts issued sales target.
Highest sales target is $8.1 while the lowest target is $7.84 showing standard deviation of 0.15%.
As many as 3 analysts have sales targets revised upside while 3 reduced sales estimates, implying a deviation of 0%.
Last month, 3 revised sales number projection on upside while 3 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast. TearLab Corporation (NASDAQ:TEAR) announced that the deviation in forecast was 0%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...